medroxyprogesterone acetate has been researched along with Thromboembolism, Venous in 17 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (17.65) | 29.6817 |
| 2010's | 11 (64.71) | 24.3611 |
| 2020's | 3 (17.65) | 2.80 |
| Authors | Studies |
|---|---|
| Cockrum, RH; Cohen, KS; Ham, SA; Snow, SG; Soo, J | 1 |
| Crandall, CJ; Manson, JE; Mehta, JM | 1 |
| Archer, DF; Boolell, M; Héroux, J; Kagan, R; Nappi, RE; Palacios, S; Panay, N; Paszkowski, T; Stute, P | 1 |
| Bahamondes, L; Bizzacchi, JMA; Fernandes, A; Melhado-Kimura, V; Montalvao, S; Quaino, SKP | 1 |
| Coupland, C; Hippisley-Cox, J; Vinogradova, Y | 1 |
| Boulet, SL; Boutot, ME; Curtis, KM; Jeng, G; Tepper, NK; Whiteman, MK | 1 |
| Gurney, EP; Nachtigall, LE; Nachtigall, MJ; Naftolin, F | 1 |
| Simon, JA | 1 |
| Scarabin, PY | 1 |
| Schreiber, CA; Sober, S | 1 |
| Jones, KP; Royer, PA | 1 |
| Bergendal, A; Hirschberg, AL; Kieler, H; Kocoska-Maras, L; Sundström, A | 1 |
| Emans, SJ; Pitts, SA | 1 |
| Rachoń, D; Teede, H | 1 |
| Chisolm, D; Kelleher, KJ; Klima, J; O'Brien, SH; Reed, S; Schwarz, EB | 1 |
| Balkwill, A; Benson, VS; Beral, V; Canonico, M; Green, J; Liu, B; Reeves, GK; Sweetland, S | 1 |
| Shapiro, S | 1 |
8 review(s) available for medroxyprogesterone acetate and Thromboembolism, Venous
| Article | Year |
|---|---|
Management of Menopausal Symptoms: A Review.
Topics: Autonomic Nervous System Diseases; Estrogen Replacement Therapy; Estrogens; Estrogens, Conjugated (USP); Female; Female Urogenital Diseases; Hot Flashes; Humans; Medroxyprogesterone Acetate; Menopause; Neoplasms; Paroxetine; Sweating; Venlafaxine Hydrochloride; Venous Thromboembolism | 2023 |
The Women's Health Initiative trial and related studies: 10 years later: a clinician's view.
Topics: Aged; Atherosclerosis; Breast Neoplasms; Calcium; Cognition; Coronary Disease; Estrogen Replacement Therapy; Estrogens, Conjugated (USP); Female; Fractures, Bone; Humans; Medroxyprogesterone Acetate; Middle Aged; Postmenopause; Progestins; Randomized Controlled Trials as Topic; Risk Assessment; Stroke; Testosterone; Venous Thromboembolism; Vitamin D; Women's Health | 2014 |
Hormone therapy and venous thromboembolism among postmenopausal women.
Topics: Administration, Cutaneous; Breast Neoplasms; Clinical Trials as Topic; Estrogen Replacement Therapy; Estrogens; Female; Humans; Medroxyprogesterone Acetate; Postmenopause; Progestins; Risk; Venous Thromboembolism | 2014 |
Postpartum contraception.
Topics: Amenorrhea; Birth Intervals; Breast Feeding; Condoms; Contraception; Contraceptive Agents, Female; Contraceptive Devices, Female; Contraceptives, Oral, Hormonal; Desogestrel; Drug Implants; Female; Humans; Intrauterine Devices, Copper; Levonorgestrel; Medroxyprogesterone Acetate; Postpartum Period; Sterilization, Tubal; Venous Thromboembolism | 2014 |
Progestins for contraception: modern delivery systems and novel formulations.
Topics: Contraceptive Agents, Female; Contraceptive Devices, Female; Contraceptives, Oral, Combined; Contraceptives, Oral, Hormonal; Drug Implants; Estrogens; Female; Humans; Intrauterine Devices, Medicated; Medroxyprogesterone Acetate; Progesterone Congeners; Progestins; Transdermal Patch; Venous Thromboembolism | 2014 |
Controversies in contraception.
Topics: Adolescent; Contraception; Contraceptive Agents, Female; Female; Humans; Hypertension; Medroxyprogesterone Acetate; Migraine Disorders; Obesity; Osteoporosis; Venous Thromboembolism; Weight Gain | 2008 |
Postmenopausal hormone therapy and the risk of venous thromboembolism.
Topics: Age Factors; Body Mass Index; Contraceptive Agents, Female; Estrogens; Female; Hormone Replacement Therapy; Humans; Medroxyprogesterone Acetate; Postmenopause; Randomized Controlled Trials as Topic; Risk; Risk Factors; Venous Thromboembolism | 2008 |
Recent epidemiological evidence relevant to the clinical management of the menopause.
Topics: Breast Neoplasms; Coronary Disease; Estrogen Replacement Therapy; Estrogens, Conjugated (USP); Evidence-Based Medicine; Female; Hot Flashes; Humans; Medroxyprogesterone Acetate; Menopause; Ovarian Neoplasms; Randomized Controlled Trials as Topic; Risk Assessment; Risk Factors; Stroke; United States; Venous Thromboembolism; Women's Health | 2007 |
1 trial(s) available for medroxyprogesterone acetate and Thromboembolism, Venous
| Article | Year |
|---|---|
Effect of the injectable contraceptive depot-medroxyprogesterone acetate on coagulation parameters in new users.
Topics: Adult; Blood Coagulation; Contraceptive Agents, Female; Delayed-Action Preparations; Female; Humans; Medroxyprogesterone Acetate; Prospective Studies; Venous Thromboembolism; Young Adult | 2017 |
8 other study(ies) available for medroxyprogesterone acetate and Thromboembolism, Venous
| Article | Year |
|---|---|
Association of Progestogens and Venous Thromboembolism Among Women of Reproductive Age.
Topics: Adult; Case-Control Studies; Female; Humans; Intrauterine Devices, Medicated; Levonorgestrel; Medroxyprogesterone Acetate; Norethindrone; Norethindrone Acetate; Progesterone; Progestins; Venous Thromboembolism | 2022 |
Oral estradiol/micronized progesterone may be associated with lower risk of venous thromboembolism compared with conjugated equine estrogens/medroxyprogesterone acetate in real-world practice.
Topics: Estradiol; Estrogen Replacement Therapy; Estrogens, Conjugated (USP); Female; Humans; Longitudinal Studies; Medroxyprogesterone Acetate; Progesterone; Retrospective Studies; Venous Thromboembolism | 2023 |
Use of hormone replacement therapy and risk of venous thromboembolism: nested case-control studies using the QResearch and CPRD databases.
Topics: Administration, Cutaneous; Adult; Aged; Case-Control Studies; Estrogens; Female; Hormone Replacement Therapy; Humans; Medroxyprogesterone Acetate; Menopause; Middle Aged; Randomized Controlled Trials as Topic; Risk Factors; United Kingdom; Venous Thromboembolism | 2019 |
Venous Thromboembolism Among Women Initiating Depot Medroxyprogesterone Acetate Immediately Postpartum.
Topics: Adolescent; Adult; Contraceptive Agents, Hormonal; Databases, Factual; Delayed-Action Preparations; Female; Humans; Incidence; Medroxyprogesterone Acetate; Postpartum Period; Risk Assessment; United States; Venous Thromboembolism; Young Adult | 2019 |
What if the Women's Health Initiative had used transdermal estradiol and oral progesterone instead?
Topics: Administration, Cutaneous; Administration, Oral; Adult; Breast Neoplasms; Cardiovascular Diseases; Dose-Response Relationship, Drug; Estrogen Replacement Therapy; Female; Hot Flashes; Humans; Medroxyprogesterone Acetate; Menopause; Middle Aged; Progesterone; Randomized Controlled Trials as Topic; Risk Assessment; Venous Thromboembolism; Women's Health | 2014 |
Risk of venous thromboembolism associated with local and systemic use of hormone therapy in peri- and postmenopausal women and in relation to type and route of administration.
Topics: Administration, Cutaneous; Administration, Oral; Case-Control Studies; Estrogen Replacement Therapy; Estrogens; Female; Humans; Logistic Models; Medroxyprogesterone Acetate; Menopause; Middle Aged; Norethindrone; Norethindrone Acetate; Odds Ratio; Perimenopause; Postmenopause; Progestins; Risk Factors; Sweden; Vagina; Venous Thromboembolism | 2016 |
Hormonal contraception use and pregnancy in adolescents with sickle cell disease: analysis of Michigan Medicaid claims.
Topics: Adolescent; Adult; Anemia, Sickle Cell; Bone Diseases, Metabolic; Contraception Behavior; Contraceptives, Oral, Hormonal; Episode of Care; Female; Hospitalization; Humans; Medicaid; Medroxyprogesterone Acetate; Michigan; Pregnancy; Pregnancy in Adolescence; Prevalence; United States; Venous Thromboembolism; Young Adult | 2011 |
Venous thromboembolism risk in relation to use of different types of postmenopausal hormone therapy in a large prospective study.
Topics: Administration, Oral; Aged; Drug Combinations; Estrogen Replacement Therapy; Estrogens; Female; Hormones; Humans; Medroxyprogesterone Acetate; Middle Aged; Postmenopause; Progestins; Proportional Hazards Models; Prospective Studies; Risk Factors; United Kingdom; Venous Thromboembolism | 2012 |